Sinopharm
1099.HK
#1949
Rank
$8.23 B
Marketcap
$2.64
Share price
-3.52%
Change (1 day)
5.19%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

EPS for Sinopharm (1099.HK)

EPS in 2022: $0.40

According to Sinopharm's latest financial reports the company's current EPS (TTM) is $0.40. In 2022 the company made an earnings per share (EPS) of $0.40 an increase over its 2021 EPS that were of $0.39.

EPS history for Sinopharm from 2006 to 2022

Annual EPS

Year EPS Change
2022$0.401.3%
2021$0.3910.33%
2020$0.3517.26%
2019$0.305.44%
2018$0.29-0.87%
2017$0.2919.44%
2016$0.2415.3%
2015$0.2117.06%
2014$0.1821.9%
2013$0.1511.82%
2012$0.1325.24%
2011$0.1131.02%
2010$0.080153.3%
2009$0.0775946.85%
2008$0.0528467.57%
2007$0.03153310.24%
2006$0.007686